Back to News
Market Impact: 0.45
What Abbott Laboratories (ABT) Said on Its Q3 Earnings Call
Source: marketbeat.com
Corporate EarningsM&A & RestructuringCompany Fundamentals
Abbott reported third-quarter sales growth of 7% and adjusted earnings-per-share growth of 9%. It also plans to separate its nutrition business into an independent publicly traded company through a tax-free distribution to shareholders; no timing or financial details of the separation were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
ABT0.65
More News
- Stock Movers: Super Micro Computer, SpaceX, Abbot Labs (Podcast)
- Our top 10 things to watch in the stock market Wednesday
- Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
- Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- 2026 Global Markets Outlook: Asset Allocation After the Great Disconnect
- Fintool Alternatives After the Microsoft Acquisition